Trade Mark Journal No.2026/040 2 October 2026

WO0000001937976 (5)

Office of origin: United States of America

Date of International Registration:13 August 2026
Date of designation in the UK: 13 August 2026
Image for mark 1937976 PABREKO

International priority date claimed: 6 August 2026 (United States of America) (50035402)
Class 5
Pharmaceutical preparations for the treatment of cancer and oncological disorders, namely, orally administered BRAF inhibitor therapies.

Fore US Bio Inc.

Representative: Neha Bhalani Chiesa Shahinian & Giantomasi PC, 105 Eisenhower Pkwy, Roseland NJ 07068, UNITED STATES OF AMERICA